Debates in Allergy Medicine: Does oral immunotherapy shorten the duration of milk and egg allergy? The pro argument.

about

Debates in Allergy Medicine: Does oral immunotherapy shorten the duration of milk and egg allergy? The pro argument.

Item

http://www.wikidata.org/entity/Q55441052

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Debates in Allergy Medicine: D ...... egg allergy? The pro argument.

@en

Debates in Allergy Medicine: D ...... egg allergy? The pro argument.

@nl

type

Item

label

Debates in Allergy Medicine: D ...... egg allergy? The pro argument.

@en

Debates in Allergy Medicine: D ...... egg allergy? The pro argument.

@nl

prefLabel

Debates in Allergy Medicine: D ...... egg allergy? The pro argument.

@en

Debates in Allergy Medicine: D ...... egg allergy? The pro argument.

@nl

P1476

Debates in Allergy Medicine: D ...... egg allergy? The pro argument

@en

P2093

Maurizio Mennini

http://www.w3.org/2001/XMLSchema#string

Valentina Pecora

http://www.w3.org/2001/XMLSchema#string

Vincenzo Fierro

http://www.w3.org/2001/XMLSchema#string

P2860

Oral and sublingual immunotherapy for egg allergy

Oral immunotherapy for milk allergy

Food allergy: epidemiology and natural history

Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract

World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines

Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability

Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel

A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism

NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis

A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40413-018-0191-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lamia Dahdah

Rocco Luigi Valluzzi

P577

2018-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29977438

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

6003149

http://www.w3.org/2001/XMLSchema#string